Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology | Rheumatology | Family Medicine
Disease Category: Psoriasis and Psoriatic Disorders
Location: United States, RI

Clinical Trial Details

Overview

Research Study Summary

Opportunity to participate: New Psoriasis Study Being Conducted

Purpose

Skin Conditions: Must have moderate to severe plaque-type psoriasis.

Name of Medication Being Tested: Etanercept (Enbrel ®)

Criteria Needed to be Entered into Study:

  • Children 4 to 17 years of age
  • Must have psoriasis for minimum of 6 months
  • Minimum 10% of total body surface area of psoriasis
  • Must have either one of the following medication history:
    • Have had or currently being treated with medication such as PUVA, UVB, UVA, Methotrexate, Cyclosporine, Retinoids
    • Poorly controlled with certain types of topical psoriasis therapy

Reasons Why You May Not Qualify: Have used Enbrel in the past

Study Specifics:

  • 52 to 57 week study with 16 visits
  • Study enrollment begins August 2004

If you are interested in receiving more information about this research study or are interested in being involved in the research,

To Learn more
Gender

Both Male and Female

Age

4 to 17 Years

Overall Status

Recruiting

Duration

57 Weeks

Facility Type

N/A

Contact

Clinical Partners, LLC
1524 Atwood Ave, Suite #330
Johnston, RI 02919
Phone: 401-454-3800

View Map

Research Center Information: Clinical Partners, LLC

CW ID: 71849

Date Last Changed: July 25, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.